logo

For the Inventor, By the Inventor

Baltimore, MD, United States of America

Lieber Institute, Inc.


USPTO Granted Patents = 9


Trademarks = 4

Forward Citations = 5

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal James C Barrow (8 out of 44 patents)

silverMedal Yifang Huang (6 out of 16 patents)

bronzeMedal Pankaj Jay Pasricha (4 out of 65 patents)

4.  Michael Steven Poslusney (4 out of 16 patents)

5.  Glen E Ernst (3 out of 15 patents)

6.  Pablo De León (2 out of 2 patents)

7.  Brady Maher (1 out of 1 patent)

8.  Florian Montel (1 out of 1 patent)

9.  Sabine Defays (1 out of 1 patent)

10.  Dominique Swinnen (1 out of 24 patents)

11.  Marikki K Laiho (1 out of 3 patents)

12.  Hester Hui Liu (1 out of 2 patents)

13.  Asma Begum (1 out of 1 patent)

14.  Tony Dorado (1 out of 1 patent)

15.  Wenjun Fan (1 out of 1 patent)


9 patents:

1. 12662482 - Compounds which inhibit RNA polymerase (2026-06-23),
2. 12234221 - Pyridine carboxamide compounds for inhibiting NAV1.8 (2025-02-25),
3. 12049467 - Substituted benzopyrazolo[1,5-a][1,4]diazepines as GABA positive allosteric modulators (2024-07-30),
4. 11993581 - Pyridazine compounds for inhibiting Nav1.8 (2024-05-28),
5. 11221329 - Treatment of neurological and neurodevelopmental diseases and disorders associated with aberrant ion channel expression and activity (2022-01-11),
6. 11136322 - Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system (2021-10-05),
7. 10934283 - COMT inhibiting methods and compositions (2021-03-02),
8. 10844070 - Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system (2020-11-24),
9. 10266534 - Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system (2019-04-23),
Company Overview
Lieber Institute, Inc. is a non-profit research organization dedicated to advancing the understanding and treatment of brain disorders, such as schizophrenia and bipolar disorder. Their team of scientists and clinicians work together to conduct cutting-edge research and develop innovative therapies to improve the lives of individuals affected by these conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Lieber Institute, Inc. USPTO Patent Assignee Logo
9 Patents

#55 in Baltimore, MD

#449 in Maryland

#32,588 in US

Baltimore, MD (US)
Baltimore, MD, United States of America

Lieber Institute, Inc.

Forward Citations = 5

18 inventors:

goldMedal James C Barrow (8 out of 44 patents)

silverMedal Yifang Huang (6 out of 16 patents)

bronzeMedal Pankaj Jay Pasricha (4 out of 65 patents)

4.  Michael Steven Poslusney (4 out of 16 patents)

5.  Glen E Ernst (3 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lieber Institute, Inc.. Retrieved from https://idiyas.com/company/lieber-institute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…